Ligand validation:7GCX

LVM: N-(4-methylpyridin-3-yl)-2-(spiro[2.3]hexan-5-yl)acetamide

LVM is a Ligand Of Interest in 7GCX designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7GCX_LVM_A_404	52%	1%	0.142	0.9	0.23	8.88	-	2	0	0	100%	0.84

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.